Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Caspritz, G.
Right arrow Articles by Hadden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caspritz, G.
Right arrow Articles by Hadden, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Immune System and Disorders
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

The Immunopharmacology of Immunotoxicology, and Immunorestoration

Gert Caspritz

Program of Immunopharmacology, University of South Florida Medical College, 12901 N. 30th Street, Tampa, Florida 33612

John Hadden

Program of Immunopharmacology, University of South Florida Medical College, 12901 N. 30th Street, Tampa, Florida 33612

The first part of this paper focuses on the secondary immunodeficiencies caused by immunosuppressive drugs and environmental chemicals. The mechanism of action and the therapeutic effects of azathioprine, glucocorticosteroids, cyclophosphamide, cyclosporin A, and anticancer drugs will be discussed. The immunotoxic actions of benzene, polychlorinated and polybrominated biphenyls, tetrachlorodibenzo-para-dioxin, polycyclic aromatic hydrocarbons, various insecticides, metals and abused drugs or drugs with side effects are also described. Immunorestorative approaches are discussed in the second part, based on our current knowledge of the immune system and the lymphokines and hormones involved in its function. The usefulness of thymic hormones, interleukin 2, macrophage growth factor/colony stimulating factor, and interferons as immunotherapeutic agents is considered. In addition, we address chemically defined drugs, such as levamisole, diethyldithiocarbamate, isoprinosine, muramyl dipeptides, azimexon, ciamexon, bestatin, tuftsin, and pyrimidinoles, and finally conclude that combined use of different immunostimulants may be the most effective way to treat the above mentioned immunodeficiencies.

  • 1. Amery WK (1979). Time in chemo-immunotherapy models: An absolute or relative variable? Int. J. Immunopharmacol. 1: 65–68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 2. Ball JK (1970). Immunosuppression and carcinogenesis: Contrasting effects with 7,12-dimethyl-benz(a)anthracene, benzo(a)pyrene and 3-methylcholanthrene. J. Natl. Cancer Inst. 44: 1–10.[Web of Science][Medline] [Order article via Infotrieve]
  • 3. Bartlett RR (1987). The pharmacology of lymphocytes. In: Handbook of Inflammation, J Morley and MA Bray (eds). Part 4, Chap. 27, Elsevier, Holland (in press).
  • 4. Bekesi JG, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1978). Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyl. Science 199: 1207–1209.[Abstract/Free Full Text]
  • 5. Bekesi JG, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1983). Altered immune function in Michigan residents exposed to polybrominated biphenyl. In: Immunotoxicology, GG Gibson, R Hubbard, and DV Parke (eds). Academic Press, London, pp. 181–191.
  • 6. Benet LZ, Bigbee JW, and Bigbee JW (1983). Biotransformation of immunotherapeutic agents. In: Advances in Immunopharmacology 2, JW Hadden, L Chedid, P Dukor, F Spreafico, and D Willoughby (eds). Pergamon Press, Oxford, pp. 17–22.
  • 7. Bicker U, and Bigbee JW (1985). Ciamexone–A new highly selective immunosuppressive compound. J. Immunopharmacol. 7(1): 127–139.[Web of Science][Medline] [Order article via Infotrieve]
  • 8. Bloom BR (1980). Interferons and the immune system. Nature 284: 593–595.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 9. Bonnyns M, and Bigbee JW (1976). Polychlorinated biphenyl-induced modification of lymphocyte response to plant mitogens in rats. Separation Experientia 32: 522–523.
  • 10. Borel JF (1981). Cyclosporin-A: Present experimental status. Transpl. Proc. 8: 344–348.
  • 11. Bruley-Rosset M, Florentin I, Kiger N, Schulz J, and Mathé G (1979). Restoration of impaired immune functions of aged animals by chronic bestatin treatment. Immunology 38: 75–83.[Web of Science][Medline] [Order article via Infotrieve]
  • 12. Cam C (1963). Une nouvelle dermatose épidemique des enfants. Ann. Dermatol. Syphil. 87: 393–397.
  • 13. Carlstedt-Duke JMB (1979). Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Cancer Res. 39: 3172–3178.[Abstract/Free Full Text]
  • 14. Carter JW, and Bigbee JW (1980). Acutely administered polychlorinated biphenyls (PCB's) decrease splenic cellularity but increase its ability to cause graft-versus-host reactions in Balb/C mice. Immunopharmacology 2: 341–347.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 15. Chen SS, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1983). Changes in surface antigens of immature thymocytes under the influence of T cell growth factor and thymic factors. Proc. Natl. Acad. Sci. 80: 5980–5984.[Abstract/Free Full Text]
  • 16. Chirigos MA, and Bigbee JW (1982). Immunorestoration by chemicals. In: Immunological Approaches to Cancer Therapeutics, E Mihich (ed). John Wiley and Sons, New York, pp. 191–240.
  • 17. Corbett TH (1975). Toxicity of polybrominated biphenyls (Firemaster BP-6) in rodents. Environ. Res. 70: 390–397.
  • 18. Dardenne M and Bach J-F (1973). Studies on thymus products. Immunology 25: 343–352.[Web of Science][Medline] [Order article via Infotrieve]
  • 19. Dean JH, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1980). The effect of adult exposure to diethylstilbestrol in the mouse: Alterations in tumor susceptibility and host resistance parameters. J. Reticuloendoth. Soc. 28: 571–583.[Web of Science][Medline] [Order article via Infotrieve]
  • 20. Dean JH, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1981). Assessment of immunotoxicity induced by the environmental chemicals 2,3,7,8-TCDD, DES and benzo(a)pyrene. In: Advances in Immunopharmacology, JW Hadden, L Chedid, P Mullen, and F Spreafico (eds). Pergamon Press, Oxford, pp. 37–50.
  • 21. Dean JH, Bigbee JW, and Bigbee JW (1987). Toxic modifications of the immune system. In: Toxicology: The Basic Science of Poisons, Casarett and Doull (eds). McMillan, New York (in press).
  • 22. DeMaeyer-Guignard J, Bigbee JW (1985). Immunomodulation by interferons: Recent developments. Interferon 6: 69–91.[Medline] [Order article via Infotrieve]
  • 23. DiLuzio NR, and Bigbee JW (1981). Polysaccharides and related substances. In: Advances in Immunopharmacology, JW Hadden, L Chedid, P Mullen, and F. Spreafico (eds). Pergamon Press, Oxford, pp. 477–490.
  • 24. Dipple A (1976). Polynuclear aromatic carcinogens. In: Chemical Carcinogens Amer. Chem. Soc. Monograph, Vol. 173, CE Seale (ed). Amer. Chem. Society, Washington, DC, pp. 245–314.
  • 25. Duncan MR, Bigbee JW, and Bigbee JW (1982). Glucocorticoid modulation of lymphokine-induced macrophage proliferation. Cell. Immunol. 67: 23–36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 26. Dunkel AE (1975). An updating on the polybrominated biphenyl disaster in Michigan. J. Am. Med. Assoc. 167: 838–843.
  • 27. Ehrke MJ, and Bigbee JW (1986). Immunoregulation by chemotherapeutic agents. In: The Reticuloendothelial System: A Comprehensive Treatise, JW Hadden and A Szentivanyi (eds). Plenum Press, New York, pp. 309–347.
  • 28. Ercegovich CD (1973). Relationship of pesticides to immune responses. Fed. Proc. 32: 2010–2016.[Web of Science][Medline] [Order article via Infotrieve]
  • 29. Faanes RB, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1980). Restoration of tumor and drug-induced immune dysfunction. In: International Symposium on New Trends in Human Immunology and Cancer Immunotherapy, B Serrou and C Rosenfeld (eds). Doin Editeurs, Paris, pp. 953–964.
  • 30. Faith RE, Bigbee JW, and Bigbee JW (1980). Effects on immunocompetence by chemicals of environmental concern. Reviews in Biochem. Tox. 2: 173–212.
  • 31. Floersheim GL (1979). Immunosuppressive effects of miscellaneous agents. In: Drugs and Immune Responsiveness, JL Turk and D Parker (eds). University Park Press, Baltimore, pp. 1–24.
  • 32. Fraker PJ (1979). The antibody-mediated and delayed type hypersensitivity response of mice exposed to polybrominated biphenyls. Toxicol. Appl. Pharmacol. 53: 1–7.[CrossRef][Web of Science]
  • 33. Gibson GG, Hubbard R, and Parke DV (eds) (1983). Immunotoxicology. Academic Press, London.
  • 34. Gillissen G (1982). Influence of cephalosporins on humoral immune response. In: The Influence of Antibiotics on the Host Parasite Relationship, H. U. Eickenberg, (ed). Springer-Verlag, New York, pp. 5–11.
  • 35. Ginsberg T, and Bigbee JW (1982). Immunopharmacology of methisoprinol. In: Frontiers in Immunomodulation, H Fudenberg and F Ambrogi (eds). Plenum Press, New York, pp. 331–348.
  • 36. Giroud JP, Roch-Arveiller M, Bigbee JW, and Bigbee JW (1980). Action comparee du levamisole du muramyldipeptide et de la tuftsine sur le chimiotactisme des polynucleaires du rat. Nouv. Rev. Fr. Hematol. 22: 69–76.[Web of Science]
  • 37. Goldstein AL, Low TLK, Thurman GB, Zatz M, Hall NR, McClure JE, Hu S-K, and Bigbee JW (1982). Thymosins and other hormone-like factors of the thymus gland. In: Immunological Approaches to Cancer Therapeutics, E Mihich (ed). John Wiley and Sons, New York, pp. 137–190.
  • 38. Good RA, Bigbee JW, and Bigbee JW (1964). Clinical considerations of the thymus in immunobiology. In: The Thymus in Immunobiology, RA Good and AE Gabrielsen (eds). Hoeber Medical Div. of Harper & Row, New York, pp. 3–48.
  • 39. Good RA, Bigbee JW, and Bigbee JW (1982). Influences of nutrition on immunity. In: Immunological Approaches to Cancer Therapeutics, E Mihich (ed). Wiley-Interscience, New York, pp. 487–504.
  • 40. Hadden JW, Cornaglia-Ferraris P, and Bigbee JW (1984). Purine analogs as immunomodulators. In: Progress in Immunology IV, Y Yamamura and T Tada (eds). Academic Press, London, pp. 1393–1407.
  • 41. Hadden JW (1984). Perspectives on the immunotherapy of AIDS. Ann. N. Y. Acad. Sci. 437: 76–87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 42. Hadden JW, Chedid L, Dukor P, Spreafico F, and Willoughby D (eds) (1983). Advances in Immunopharmacology 2. Pergamon Press, Oxford.
  • 43. Hadden JW (1983). Chemically defined immunotherapeutic agents. In: 13th International Cancer Congress, EA Mirand, WB Hutchinson, and E Mihich (eds). Part E. Cancer Management. Alan Liss Inc., New York, pp. 273–286.
  • 44. Hadden JW (1983). Immunotoxicology: The prospects for immunorestoration. In: Immunotoxicology, G Gibson, R Hubbard, and DV Parke (eds). Academic Press, London, pp. 329–342.
  • 45. Hadden JW and Stewart WE, II (eds) (1981). The Lymphokines. Humana Press, New Jersey.
  • 46. Hadden JW, Bigbee JW, Bigbee JW, and Bigbee JW (1981). Lymphokine induced macrophage proliferation and activation. In: Lymphokine and Thymic Hormones, A Goldstein and M Chirigos (eds). Raven Press, New York, pp. 159–172.
  • 47. Hadden JW, Giner-Sorolla A, Hadden E, Ikehara S, Pahwa R, Coffey R, Castellazzi A-M, Bigbee JW, Bigbee JW, and Bigbee JW (1982). NPT 16416: A levamisole-like purine with immunomodulatory effects. Int. J. Immunopharmacol. 4: 287–292.
  • 48. Hadden JW and Giner-Sorolla A (1981). Isoprinosine and NPT 15392: Modulators of lymphocyte and macrophage development and function. In: Augmenting Agents in Cancer Therapy, EM Hersh, MA Chirigos, and MJ Mastrangelo (eds). Raven Press, New York, pp. 497–522.
  • 49. Hadden JW (1987). Current status of the immunotherapy of AIDS and the AIDS-related complex. In: AIDS and Other Manifestations of HTLV III Infections, G Wormser (ed). Noyes Publications, New Jersey (in press).
  • 50. Hadden JW, Specter S, Galy A, Touraine J-L, Bigbee JW (1986). Thymic hormones, interleukins, endotoxins and thymomimetic drugs in T lymphotye ontogeny. In: Advances in Immunopharmacology 3, L Chedid, JW Hadden, F Spreafico, P Dukor, and D Willoughby (eds). Pergamon Press, Oxford, pp. 487–497.
  • 51. Hersh EM (1983). Immunotherapy of human cancer: Current status and prospects for future development. In: Advances in Immunopharmacology 2, J Hadden, L Chedid, P Dukor, F Spreafico, and D Willoughby (eds). Pergamon Press, Oxford, pp. 487–499.
  • 52. Hersh EM, Chirigos MA, and Mastrangelo JJ (eds) (1981). Agumenting Agents in Cancer Therapy. Raven Press, New York.
  • 53. Hiestand PC, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1985). The immunosuppressive profile of a new natural cyclosporine analogue: Nva2-cyclosporine. Transpl. Proc. 17(1): 1362–1364.[Web of Science]
  • 54. Hiestand PC, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1986). Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc. Natl. Acad. Sci. 83: 2599–2603.[Abstract/Free Full Text]
  • 55. Hinsdill RD, Bigbee JW, and Bigbee JW (1980). Immunosuppression in mice induced by dioxin (TCDD) in feed. J. Environ. Pathol. Toxicol. 3: 401–425.
  • 56. Higgins PG (1984). Interferons. J. Clin. Pathol. 37: 109–116.[Free Full Text]
  • 57. Jackson TF, and Bigbee JW (1974). A toxic syndrome associated with the feeding of polybrominated biphenyl-contaminated protein concentrate to dairy cattle. J. Am. Vet. Med. Association 165: 437–439.
  • 58. Johnson HM (1982). Modulation of the immune response by interferons and their inducers. In: Immunological Approaches to Cancer Therapeutics, E Mihich (ed). John Wiley and Sons, New York, pp. 241–256.
  • 59. Kirkpatrick CH, and Bigbee JW (1981). Transfer factor: Progress toward isolation and characterization. In: The Lymphokines: Biochemistry and Biological Activity, JW Hadden and WE Stewart, II (eds). Humana Press, New Jersey, pp. 261–274.
  • 60. Koller LD, and Bigbee JW (1973). Reduction of antibody to Pseudorabies virus in polychlorinated biphenyl-exposed rabbits. Am. J. Vet. Res. 34: 1605–1606.[Web of Science][Medline] [Order article via Infotrieve]
  • 61. Kouri RE, Ratrie H, III, Bigbee JW, Bigbee JW, and Bigbee JW (1975). Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Life Sci. 15: 1585–1595.[CrossRef][Web of Science]
  • 62. Krim M (1980). Towards tumor therapy with interferons. Part I. Interferons: Production and properties. Part II. Interferons: In vivo effects. Blood 55: 711–721, 875–884.[Free Full Text]
  • 63. Lange A, Bigbee JW, Bigbee JW, and Bigbee JW (1973). Serum immunoglobulin levels in workers exposed to benzene, toluene, and xylene. Int. Arch. Arbeitsmed. 31: 37–44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 64. Lederer E, and Bigbee JW (1982). Immunomodulation by synthetic muramyl peptides and trehalose diesters. In: Immunological Approaches to Cancer Therapeutics, E Mihich (ed). John Wiley and Sons, New York, pp. 107–136.
  • 65. Loose LD, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1978). Impaired host resistance to endotoxin and malaria in polychlorinated biphenyl-and hexachlorobenzene-treated mice. Infect. Immun. 20: 30–35.[Abstract/Free Full Text]
  • 66. Loose LD, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1978). Environmental chemical-induced immune dysfunction. Ecotoxicol. Environ. Safety 2: 173–198.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 67. Loose LD, Bigbee JW, and Bigbee JW (1978). Influence of cadmium on the phagocytic and microbicidal activity of murine peritoneal macrophages, pulmonary alveolar macrophages and polymorphonuclear neutrophils. Infect. Immun. 22: 378–381.[Abstract/Free Full Text]
  • 68. Luster MI, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1980). The effect of adult exposure to diethylstilbestrol in the mouse. Alterations in immunological function. J. Reticuloendothel. Soc. 28: 561–569.[Web of Science][Medline] [Order article via Infotrieve]
  • 69. Luster MI, Bigbee JW, Bigbee JW, and Bigbee JW (1980). Laboratory studies on polybrominated biphenyl-induced immune alterations following lowlevel chronic or pre/postnatal exposure. Int. J. Immunopharmacol. 2: 69–80.[CrossRef][Web of Science]
  • 70. Luster MI, and Bigbee JW (1982). Immunological hypersensitivity resulting from environmental or occupational exposure to chemicals: A state-of-the-art workshop summary. Fundamental & Appl. Toxicol. 2: 327–330.[CrossRef][Medline] [Order article via Infotrieve]
  • 71. Luster MI, Bigbee JW, and Bigbee JW (1978). Effects of polybrominated biphenyls (PBB) on immune response in rodents. Environ. Health Perspect. 23: 227–232.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 72. Makinodan T and Yunis E (eds) (1976). Immunology and Aging. Plenum Press, New York.
  • 73. Malaise MG, Franchimont P, Bach-Anderson R, Gerber H, Stocker H, Hauwaert C, Danneskiold-Samsoe B, Bigbee JW, Bigbee JW, and Bigbee JW (1985). Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study. Lancet 1: 832–836.[Web of Science][Medline] [Order article via Infotrieve]
  • 74. Malmgren RA, Bennison BE, and McKinley TW, Jr (1952). Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents. Proc. Soc. Exp. Biol. Med. 70: 484–488.
  • 75. McConnell EE (1980). Acute and chronic toxicity, carcinogenesis, reproduction, teratogenesis, and mutagenesis in animals. In: Introduction to Environmental Toxicology, FE Guthrie and JJ Perry (eds). Elsevier/North Holland Biomedical Press, New York, pp. 241–266.
  • 76. Metcalf D (1986). The molecular biology and functions of the GM colony stimulating factors. Blood 67(2): 251–267.[Web of Science][Medline] [Order article via Infotrieve]
  • 77. Metcalf D (1985). Colony stimulating factors. Science 229: 16–22.[Abstract/Free Full Text]
  • 78. Najjar VA, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1981). Tuftsin (Thr-Lys-Pro-Arg), a physiological activator of phagocytic cells: A possible role in cancer suppression and therapy. In: Augmenting Agents in Cancer Therapy, EM Hersh, MA Chirigos, and MJ Mastrangelo (eds). Raven Press, New York, pp. 459–478.
  • 79. Nicholson WJ, and Bigbee JW (1979). Health effects of halogenated aromatic hydrocarbons. Ann. N.Y. Acad. Sci. 320: 1–730.[Medline] [Order article via Infotrieve]
  • 80. Nishioka K, Bigbee JW, and Bigbee JW (1981). Tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activities. Life Sci. 28: 1081–1090.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 81. NN (1977). Twelve months after Seveso. Nature (London) 268: 90.[Web of Science][Medline] [Order article via Infotrieve]
  • 82. Parillo JE, and Bigbee JW (1979). Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 19: 179–201.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 83. Pitot HC, Bigbee JW, Bigbee JW, and Bigbee JW (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40: 3616–3620.[Abstract/Free Full Text]
  • 84. Poland A, and Bigbee JW (1976). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J. Biol. Chem. 251: 4936–4945.[Abstract/Free Full Text]
  • 85. Pompidou A, Touraine JL, Simon-Lavoine N, and Bigbee JW (1980). Immunomodulatory effects of cyclomunine in vitro. Int. J. Immunopharmacol. 2: 141–144.[CrossRef][Web of Science]
  • 86. Reggiani G. (1980). Acute human exposure to TCDD in Seveso, Italy. J. Toxicol. Environ. Health 6: 27–43.[Web of Science][Medline] [Order article via Infotrieve]
  • 87. Renoux G (1978). Modulation of immunity by levamisole. Pharma. Thera. 2: 397–423.
  • 88. Renoux G, and Bigbee JW (1981). Immunologic activity of DTC: Potential for cancer therapy. In: Augmenting Agents in Cancer Therapy, EM Hersh, MA Chirigos, and MJ Mastrangelo (eds). Raven Press, New York, pp. 427–440.
  • 89. Renoux G, and Bigbee JW (1971). Effet immunostimulant d'un imidothiazole sur l'immunisation des souris par Brucella abortus. C.R. Acad. Sci. (Paris) 269D: 1467–1469.
  • 90. Rohr U, Bigbee JW, and Bigbee JW (1985). Freisetzung von Entzuendugsmediatoren durch Pestizide. Umweltmedizin 2: 23–27.
  • 91. Sadlik JR, Bigbee JW, and Bigbee JW (1983). Lymphokine induced macrophage proliferation: Purification and characterization of antigen induced MGF/CSF. In: Advances in Immunopharmacology 2, JW Hadden, L Chedid, P Dukor, F Spreafico, and D Willoughby (eds). Pergamon Press, Oxford, pp. 221–227.
  • 92. Schewtz BW, Bigbee JW, and Bigbee JW (1973). Toxicological properties of pentachlorophenol relative to its content of chlorinated dibenzo-p-dioxins. Pharmacologist 15: 395–403.
  • 93. Schulof RS, and Bigbee JW (1981). Thymosins and other thymic hormones. In: The Lymphokines, J Hadden and W Stewart, II (eds). Humana Press, New Jersey, pp. 397–422.
  • 94. Sen GC (1984). Biochemical pathways in interferon action. Pharmac. Ther. 24: 235–257.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 95. Sharma RP, Bigbee JW, and Bigbee JW (1978). Immunotoxicologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Toxicol. Appl. Pharmacol. 45: 333 (Abstract).
  • 96. Shigematsu N, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1978). Respiratory involvement in PCB poisoning. Environ. Res. 16: 92–100.[Medline] [Order article via Infotrieve]
  • 97. Silkworth JB, and Bigbee JW (1978). Cell-mediated immunity in mice fed either Aroclor 1016 or hexachlorobenzene. Toxicol. Appl. Pharmacol. 40: 326–327.
  • 98. Silkworth JB, and Bigbee JW (1979). PCB and HCB induced alteration of lymphocyte blastogenesis. Toxicol. Appl. Pharmacol. 49: 86–91.
  • 99. Simon LN, Bigbee JW, Bigbee JW, and Bigbee JW (1983). Isoprinosine and NPT 15392: Immunomodulation and cancer. In: Biological Response Modifiers in Human Oncology and Immunology, T Klein, S Specter, H Freidman, and A Szentivanyi (eds). Plenum Press, New York, pp. 241–259.
  • 100. Smolik R, Grzybek-Hryncewicz K, Bigbee JW, and Bigbee JW (1973). Serum complement levels in workers exposed to benzene, toluene, and xylene. Int. Arch. Arbeitsmed. 31: 243–347.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 101. Spreafico F, and Bigbee JW (1977). Immunosuppressive agents. In: Immunopharmacology 3, J Hadden, R Coffey, and F Spreafico (eds). Plenum Medical Book Company, New York, pp. 245–278.
  • 102. Spreafico F, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1983). On the mode of action of immunodepressive agents. In: Advances in Immunopharmacology 2, J Hadden, L Chedid, P Dukor, F Spreafico, and D Willoughby (eds). Pergamon Press, Oxford, pp. 745–752.
  • 103. Stjernsward J (1966). Effect of noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro. J. Natl. Cancer Inst. 36: 1189–1195.[Web of Science][Medline] [Order article via Infotrieve]
  • 104. Stringfellow D (1981). 6-aryl pyrimidinoles: Interferon inducers-immunomodulators-antiviral and antineoplastic agents. In: Augmenting Agents in Cancer Therapy, E Hersh, M Chirigos, and M Mastrangelo (eds). Raven Press, New York, pp. 215–228.
  • 105. Symoens J, and Bigbee JW (1977). Levamisole in the modulation of the immune response: The current experimental and clinical state. J. Reticuloendothel. Soc. 21: 175–221.[Web of Science][Medline] [Order article via Infotrieve]
  • 106. Thomas PJ, and Bigbee JW (1978). Effect of polychlorinated biphenyls on the immune responses of Rhesus monkeys and mice. Toxicol. Appl. Pharmacol. 44: 41–52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 107. Toy JL (1983). The interferons. Clin. Exp. Immunol. 54: 1–13.[Web of Science][Medline] [Order article via Infotrieve]
  • 108. Thomas PT, and Bigbee JW (1980). Perinatal PCB exposure and its effects on the immune system of young rabbits. Drug Chem. Toxicol. 3: 173–184.[Web of Science][Medline] [Order article via Infotrieve]
  • 109. Tschirley IH (1986). Dioxin. Scientific American 254(2): 29–35.[Web of Science][Medline] [Order article via Infotrieve]
  • 110. Umezawa H (ed) (1981). Small Molecular Immunomodifiers of Microbial Origin. Pergamon Press, Oxford.
  • 111. Vos JG, Bigbee JW, and Bigbee JW (1980). Immune alterations. In: Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products, RD Kimbrough (ed). Raven Press, New York, pp. 241–266.
  • 112. Vos JG, Kreeftenberg JG, Engel HWB, Minderhoud A, and VanNoorle-Jansen LM (1978). Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression and decreased resistance to infection: Endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 9: 75–86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 113. Vos JG, and Bigbee JW (1972). Immunosuppressive activity of a polychlorinated biphenyl preparation on the humoral immune response in Guinea pigs. Toxicol. Appl. Pharmacol. 21: 549–555.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 114. Vos JG and VanDriel-Grootenhuis L (1972). PCB-induced suppression of the humoral and cell mediated immunity in guinea pigs. Sci. Total. Environ. 1: 289–295.[CrossRef][Medline] [Order article via Infotrieve]
  • 115. Vos JG, Bigbee JW, and Bigbee JW (1973). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ. Health Perspect. 5: 149–162.[Medline] [Order article via Infotrieve]
  • 116. Vos JG, Bigbee JW, Bigbee JW, Bigbee JW, and Bigbee JW (1979). Effect of hexachlorobenzene on the immune system of rats following combined pre and postnatal exposure. Drug Chem. Toxicol. 2: 61–76.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 117. Wada O, Bigbee JW, Bigbee JW, and Bigbee JW (1967). Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem. Pharmacol. 17: 595–603.[CrossRef][Web of Science]
  • 118. Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Pingchang Chow E, Bigbee JW, Bigbee JW, and Bigbee JW (1986). Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320: 77–80.[CrossRef][Medline] [Order article via Infotrieve]
  • 119. Wanebo HJ, Bigbee JW, Bigbee JW, and Bigbee JW (1978). Immunocompetence testing in patients with one of the four common operable cancers–A review. Clinical Bulletin 8: 15–22.[Web of Science][Medline] [Order article via Infotrieve]
  • 120. Wierda D, Bigbee JW, and Bigbee JW (1981). Immunotoxicity in C57BL/6 mice exposed to benzene and Aroclor 1254. Toxicol. Appl. Pharmacol. 60: 410–417.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 121. Wilson N, Bigbee JW, Bigbee JW, and Bigbee JW (1979). Influence of polybrominated biphenyl on the splenic antibody response in the mouse. In: Abst. 18th Annual Meeting of Toxicol. 177.
  • 122. Zedeck MS (1980). Polycyclic aromatic hydrocarbons, a review. J. Environ. Pathol. Toxicol. 3: 537–567.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 15, No. 3, 320-332 (1987)
DOI: 10.1177/019262338701500310
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Caspritz, G.
Right arrow Articles by Hadden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caspritz, G.
Right arrow Articles by Hadden, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Immune System and Disorders
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?